Abstract:Resistin plays an important role in the pathophysiology of obesity-mediated insulin resistance in mice. However, the biology of resistin in humans is quite different from that in rodents. Therefore, the association between resistin and insulin resistance remains unclear in humans. Here, we tested whether and how the endocannabinoid system (ECS) control circulating peripheral blood mononuclear cells (PBMCs) that produce resistin and infiltrate into the adipose tissue, heart, skeletal muscle, and liver, resulting in inflammation and insulin resistance. Using human PBMCs, we investigate whether the ECS is connected to human resistin. To test whether the ECS regulates inflammation and insulin resistance in vivo, we used 2 animal models such as “humanized” nonobese diabetic/Shi-severe combined immunodeficient interleukin-2Rγ (null) (NOG) mice and “humanized” resistin mouse models, which mimic human body. In human atheromatous plaques, cannabinoid 1 receptor (CB1R)-positive macrophage was colocalized with the resistin expression. In addition, resistin was exclusively expressed in the sorted CB1R-positive cells from human PBMCs. In CB1R-positive cells, endocannabinoid ligands induced resistin expression via the p38–Sp1 pathway. In both mouse models, a high-fat diet increased the accumulation of endocannabinoid ligands in adipose tissue, which recruited the CB1R-positive cells that secrete resistin, leading to adipose tissue inflammation and insulin resistance. This phenomenon was suppressed by CB1R blockade or in resistin knockout mice. Interestingly, this process was accompanied by mitochondrial change that was induced by resistin treatment. These results provide important insights into the ECS–resistin axis, leading to the development of metabolic diseases. Therefore, the regulation of resistin via the CB1R could be a potential therapeutic strategy for cardiometabolic diseases.

Resistin, a Novel Host Defense Peptide of Innate Immunity

[Resistin: It's Role in Insulin Resistance and Mechanism of Action].

Advance on the Mechanism How Resistin Induces Insulin Resistance

Resistin: A journey from metabolism to cancer

Mechanisms and regulation of defensins in host defense

Resistin: Potential biomarker and therapeutic target in atherosclerosis

Transcription factor Sp1 and resistin

Resistin-like molecule family and its biological functions

Host Defense Peptides in Nutrition and Diseases: A Contributor of Immunology Modulation

Resistin Obesity and Type 2 Diabetes

Differential Dimerization and Association among Resistin Family Proteins with Implications for Functional Specificity.

Activation of the Porcine Alveolar Macrophages Via Toll-Like Receptor 4/Nf-Κb Mediated Pathway Provides a Mechanism of Resistin Leading to Inflammation.

Progress in relationship between resistin and obesity, insulin resistance as well as cardiovascular disease

Defensins: A Double-Edged Sword in Host Immunity

Relation of Circulating Resistin to Insulin Resistance in Type 2 Diabetes and Obesity: A Systematic Review and Meta-Analysis

The Role of Resistin in Obesity and Diabetes

Understanding the Roles of Host Defense Peptides in Immune Modulation: From Antimicrobial Action to Potential as Adjuvants

Regulatory Role of Defensins in Inflammatory Bowel Disease

[Advances in the Research of Human Defensins].

Recent advances in the research and development of human defensins.

Resistin Regulates Inflammation and Insulin Resistance in Humans via the Endocannabinoid System